Webinar On Demand:
Real-Time High Throughput Viral Cytopathic Assays for Vaccine Development, Neutralizing Antibody Screening, and Anti-Viral Therapy
Across a broad array of applications, virology assays typically monitor changes in the infected host cell over time. The traditional methods for quantifying these virus-induced cytopathic effects are often labor intensive and only yield endpoint data.
Using gold-electrode biosensors and combined imaging, the xCELLigence family of instruments continuously and non-invasively monitor virus-induced changes in host cell number, size, attachment strength, and barrier function. This composite readout is an exceptionally sensitive means of tracking the entire life cycle of a virus and interrogating virus-host interactions.
In this webinar we will demonstrate how, with a simple workflow and minimal hands-on time, xCELLigence assays yield an abundance of quantitative kinetic information that is being used in both industry and academia for:
- Virus titer determination
- Quantification of neutralizing antibodies
- Antiviral therapy development
- Evaluating oncolytic virus efficacy
- Assessing virus quality/potency/fitness
Brandon Lamarche, Ph.D.
Principal Scientist, Head of xCELLigence Application Development
Agilent Technologies, Cell Analysis Division
For Research Use Only. Not for use in diagnostic procedures.